BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34406037)

  • 1. Induction and Elimination of Prophages Using CRISPR Interference.
    Cornuault JK; Moineau S
    CRISPR J; 2021 Aug; 4(4):549-557. PubMed ID: 34406037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPRpi: Inducing and Curing Prophage Using the CRISPR Interference.
    Cornuault JK
    Methods Mol Biol; 2024; 2793():257-271. PubMed ID: 38526735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of spontaneous induction of lambdoid prophages in Escherichia coli cultures: simple procedures with possible biotechnological applications.
    Czyz A; Los M; Wrobel B; Wegrzyn G
    BMC Biotechnol; 2001; 1():1. PubMed ID: 11316465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abundant and diverse clustered regularly interspaced short palindromic repeat spacers in Clostridium difficile strains and prophages target multiple phage types within this pathogen.
    Hargreaves KR; Flores CO; Lawley TD; Clokie MR
    mBio; 2014 Aug; 5(5):e01045-13. PubMed ID: 25161187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage crosstalk: coordination of prophage induction by trans-acting antirepressors.
    Lemire S; Figueroa-Bossi N; Bossi L
    PLoS Genet; 2011 Jun; 7(6):e1002149. PubMed ID: 21731505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of Single Prophage Carrying a CRISPR/cas System in "Candidatus Liberibacter asiaticus" Strains in Southern China.
    Zheng Z; Bao M; Wu F; Chen J; Deng X
    PLoS One; 2016; 11(1):e0146422. PubMed ID: 26741827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli CRISPR arrays from early life fecal samples preferentially target prophages.
    Dion MB; Shah SA; Deng L; Thorsen J; Stokholm J; Krogfelt KA; Schjørring S; Horvath P; Allard A; Nielsen DS; Petit MA; Moineau S
    ISME J; 2024 Jan; 18(1):. PubMed ID: 38366192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic-Prophage-Encoded Small Protein DicB Protects
    Ragunathan PT; Vanderpool CK
    J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31527115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yet another way that phage λ manipulates its Escherichia coli host: λrexB is involved in the lysogenic-lytic switch.
    Engelberg-Kulka H; Kumar S
    Mol Microbiol; 2015 May; 96(4):689-93. PubMed ID: 25684601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9.
    Hynes AP; Rousseau GM; Lemay ML; Horvath P; Romero DA; Fremaux C; Moineau S
    Nat Microbiol; 2017 Oct; 2(10):1374-1380. PubMed ID: 28785032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different expression patterns of genes from the exo-xis region of bacteriophage λ and Shiga toxin-converting bacteriophage Ф24B following infection or prophage induction in Escherichia coli.
    Bloch S; Nejman-Faleńczyk B; Dydecka A; Łoś JM; Felczykowska A; Węgrzyn A; Węgrzyn G
    PLoS One; 2014; 9(10):e108233. PubMed ID: 25310402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly efficient in vivo plasmid editing tool based on CRISPR-Cas12a and phage λ Red recombineering.
    Geng Y; Yan H; Li P; Ren G; Guo X; Yin P; Zhang L; Qian Z; Zhao Z; Sun YC
    J Genet Genomics; 2019 Sep; 46(9):455-458. PubMed ID: 31607505
    [No Abstract]   [Full Text] [Related]  

  • 13. A plasmid toolset for CRISPR-mediated genome editing and CRISPRi gene regulation in Escherichia coli.
    Jervis AJ; Hanko EKR; Dunstan MS; Robinson CJ; Takano E; Scrutton NS
    Microb Biotechnol; 2021 May; 14(3):1120-1129. PubMed ID: 33710766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic relationship of prophages is affected by CRISPR selection in Group A Streptococcus.
    Yamada S; Shibasaki M; Murase K; Watanabe T; Aikawa C; Nozawa T; Nakagawa I
    BMC Microbiol; 2019 Jan; 19(1):24. PubMed ID: 30691408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophages are associated with extensive CRISPR-Cas auto-immunity.
    Nobrega FL; Walinga H; Dutilh BE; Brouns SJJ
    Nucleic Acids Res; 2020 Dec; 48(21):12074-12084. PubMed ID: 33219687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The driving force of prophages and CRISPR-Cas system in the evolution of Cronobacter sakazakii.
    Zeng H; Zhang J; Li C; Xie T; Ling N; Wu Q; Ye Y
    Sci Rep; 2017 Jan; 7():40206. PubMed ID: 28057934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas phage defense systems and prophages in Candidatus Accumulibacter.
    Deng X; Yuan J; Chen L; Chen H; Wei C; Nielsen PH; Wuertz S; Qiu G
    Water Res; 2023 May; 235():119906. PubMed ID: 37004306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system.
    Kiro R; Shitrit D; Qimron U
    RNA Biol; 2014; 11(1):42-4. PubMed ID: 24457913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global analysis of host response to induction of a latent bacteriophage.
    Osterhout RE; Figueroa IA; Keasling JD; Arkin AP
    BMC Microbiol; 2007 Aug; 7():82. PubMed ID: 17764558
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Roszniowski B; McClean S; Drulis-Kawa Z
    Viruses; 2018 May; 10(6):. PubMed ID: 29857552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.